Advances in BK Virus Complications in Organ Transplantation and Beyond

Reactivation of BK virus (BKV) remains a dreaded complication in immunosuppressed states. Conventionally, BKV is known as a cause for BKV-associated nephropathy and allograft dysfunction in kidney transplant recipients. However, emerging studies have shown its negative impact on native kidney functi...

Full description

Bibliographic Details
Main Authors: Abraham Cohen-Bucay, Silvia E. Ramirez-Andrade, Craig E. Gordon, Jean M. Francis, Vipul C. Chitalia
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Kidney Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059520302053
_version_ 1818728657809571840
author Abraham Cohen-Bucay
Silvia E. Ramirez-Andrade
Craig E. Gordon
Jean M. Francis
Vipul C. Chitalia
author_facet Abraham Cohen-Bucay
Silvia E. Ramirez-Andrade
Craig E. Gordon
Jean M. Francis
Vipul C. Chitalia
author_sort Abraham Cohen-Bucay
collection DOAJ
description Reactivation of BK virus (BKV) remains a dreaded complication in immunosuppressed states. Conventionally, BKV is known as a cause for BKV-associated nephropathy and allograft dysfunction in kidney transplant recipients. However, emerging studies have shown its negative impact on native kidney function and patient survival in other transplants and its potential role in diseases such as cancer. Because BKV-associated nephropathy is driven by immunosuppression, reduction in the latter is a convenient standard of care. However, this strategy is risk prone due to the development of donor-specific antibodies affecting long-term allograft survival. Despite its pathogenic role, there is a distinct lack of effective anti-BKV therapeutics. This limitation combined with increased morbidity and health care cost of BKV-associated diseases add to the complexity of BKV management. While summarizing recent advances in the pathogenesis of BKV-associated nephropathy and its reactivation in other organ transplants, this review illustrates the limitations of current and emerging therapeutic options and provides a compelling argument for an effective targeted anti-BKV drug.
first_indexed 2024-12-17T22:33:29Z
format Article
id doaj.art-fe9abad0340a4ecb8d972beaad88bec2
institution Directory Open Access Journal
issn 2590-0595
language English
last_indexed 2024-12-17T22:33:29Z
publishDate 2020-11-01
publisher Elsevier
record_format Article
series Kidney Medicine
spelling doaj.art-fe9abad0340a4ecb8d972beaad88bec22022-12-21T21:30:08ZengElsevierKidney Medicine2590-05952020-11-0126771786Advances in BK Virus Complications in Organ Transplantation and BeyondAbraham Cohen-Bucay0Silvia E. Ramirez-Andrade1Craig E. Gordon2Jean M. Francis3Vipul C. Chitalia4Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico; Nephrology Department, American British Cowdray Medical Center, Mexico City, MexicoDepartment of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, MexicoDivision of Nephrology, Tufts Medical Center, Boston, MASection of Nephrology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Renal Section, Boston University Medical Center, Boston, MARenal Section, Boston University Medical Center, Boston, MA; Institute of Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA; Veteran Affairs Boston Healthcare System, Boston, MA; Address for Correspondence: Vipul Chitalia, MD, PhD, Department of Medicine, EBRX X-540, Boston University Medical Center, 650 Albany St, 5th Fl, Boston, MA 02118.Reactivation of BK virus (BKV) remains a dreaded complication in immunosuppressed states. Conventionally, BKV is known as a cause for BKV-associated nephropathy and allograft dysfunction in kidney transplant recipients. However, emerging studies have shown its negative impact on native kidney function and patient survival in other transplants and its potential role in diseases such as cancer. Because BKV-associated nephropathy is driven by immunosuppression, reduction in the latter is a convenient standard of care. However, this strategy is risk prone due to the development of donor-specific antibodies affecting long-term allograft survival. Despite its pathogenic role, there is a distinct lack of effective anti-BKV therapeutics. This limitation combined with increased morbidity and health care cost of BKV-associated diseases add to the complexity of BKV management. While summarizing recent advances in the pathogenesis of BKV-associated nephropathy and its reactivation in other organ transplants, this review illustrates the limitations of current and emerging therapeutic options and provides a compelling argument for an effective targeted anti-BKV drug.http://www.sciencedirect.com/science/article/pii/S2590059520302053BK virus, transplantation
spellingShingle Abraham Cohen-Bucay
Silvia E. Ramirez-Andrade
Craig E. Gordon
Jean M. Francis
Vipul C. Chitalia
Advances in BK Virus Complications in Organ Transplantation and Beyond
Kidney Medicine
BK virus, transplantation
title Advances in BK Virus Complications in Organ Transplantation and Beyond
title_full Advances in BK Virus Complications in Organ Transplantation and Beyond
title_fullStr Advances in BK Virus Complications in Organ Transplantation and Beyond
title_full_unstemmed Advances in BK Virus Complications in Organ Transplantation and Beyond
title_short Advances in BK Virus Complications in Organ Transplantation and Beyond
title_sort advances in bk virus complications in organ transplantation and beyond
topic BK virus, transplantation
url http://www.sciencedirect.com/science/article/pii/S2590059520302053
work_keys_str_mv AT abrahamcohenbucay advancesinbkviruscomplicationsinorgantransplantationandbeyond
AT silviaeramirezandrade advancesinbkviruscomplicationsinorgantransplantationandbeyond
AT craigegordon advancesinbkviruscomplicationsinorgantransplantationandbeyond
AT jeanmfrancis advancesinbkviruscomplicationsinorgantransplantationandbeyond
AT vipulcchitalia advancesinbkviruscomplicationsinorgantransplantationandbeyond